Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference
The Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) convened virtually on 4 November 2021. The WCGCCC is an interactive multi-disciplinary conference attended by health care professionals, including surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals from across four Western Canadian provinces, British Columbia, Alberta, Saskatchewan, and Manitoba, who are involved in the care of patients with gastrointestinal cancer. They participated in presentation and discussion sessions for the purpose of developing recommendations on the role of systemic therapy and its optimal sequence in patients with resectable metastatic colorectal cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Current oncology (Toronto, Ont.) - 29(2022), 3 vom: 08. März, Seite 1796-1807 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ahmed, Shahid [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adjuvant therapy |
---|
Anmerkungen: |
Date Completed 14.04.2022 Date Revised 06.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/curroncol29030147 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338536671 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM338536671 | ||
003 | DE-627 | ||
005 | 20240306232107.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/curroncol29030147 |2 doi | |
028 | 5 | 2 | |a pubmed24n1318.xml |
035 | |a (DE-627)NLM338536671 | ||
035 | |a (NLM)35323347 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ahmed, Shahid |e verfasserin |4 aut | |
245 | 1 | 0 | |a Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.04.2022 | ||
500 | |a Date Revised 06.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) convened virtually on 4 November 2021. The WCGCCC is an interactive multi-disciplinary conference attended by health care professionals, including surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals from across four Western Canadian provinces, British Columbia, Alberta, Saskatchewan, and Manitoba, who are involved in the care of patients with gastrointestinal cancer. They participated in presentation and discussion sessions for the purpose of developing recommendations on the role of systemic therapy and its optimal sequence in patients with resectable metastatic colorectal cancer | ||
650 | 4 | |a Consensus Development Conference | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a CRLM | |
650 | 4 | |a adjuvant therapy | |
650 | 4 | |a chemotherapy | |
650 | 4 | |a colorectal liver metastases | |
650 | 4 | |a consensus | |
650 | 4 | |a metastasectomy | |
650 | 4 | |a surgery | |
650 | 4 | |a systemic therapy | |
700 | 1 | |a Bosma, Nicholas |e verfasserin |4 aut | |
700 | 1 | |a Moser, Michael |e verfasserin |4 aut | |
700 | 1 | |a Ahmed, Shahida |e verfasserin |4 aut | |
700 | 1 | |a Brunet, Bryan |e verfasserin |4 aut | |
700 | 1 | |a Davies, Janine |e verfasserin |4 aut | |
700 | 1 | |a Doll, Corinne |e verfasserin |4 aut | |
700 | 1 | |a Dueck, Dorie-Anna |e verfasserin |4 aut | |
700 | 1 | |a Kim, Christina A |e verfasserin |4 aut | |
700 | 1 | |a Ji, Shuying |e verfasserin |4 aut | |
700 | 1 | |a Le, Duc |e verfasserin |4 aut | |
700 | 1 | |a Lee-Ying, Richard |e verfasserin |4 aut | |
700 | 1 | |a Lim, Howard |e verfasserin |4 aut | |
700 | 1 | |a McGhie, John Paul |e verfasserin |4 aut | |
700 | 1 | |a Mulder, Karen |e verfasserin |4 aut | |
700 | 1 | |a Park, Jason |e verfasserin |4 aut | |
700 | 1 | |a Ravi, Deepti |e verfasserin |4 aut | |
700 | 1 | |a Renouf, Daniel J |e verfasserin |4 aut | |
700 | 1 | |a Schellenberg, Devin |e verfasserin |4 aut | |
700 | 1 | |a Wong, Ralph P W |e verfasserin |4 aut | |
700 | 1 | |a Zaidi, Adnan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current oncology (Toronto, Ont.) |d 1998 |g 29(2022), 3 vom: 08. März, Seite 1796-1807 |w (DE-627)NLM09444482X |x 1718-7729 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2022 |g number:3 |g day:08 |g month:03 |g pages:1796-1807 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/curroncol29030147 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2022 |e 3 |b 08 |c 03 |h 1796-1807 |